Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19812200rdf:typepubmed:Citationlld:pubmed
pubmed-article:19812200lifeskim:mentionsumls-concept:C0034850lld:lifeskim
pubmed-article:19812200lifeskim:mentionsumls-concept:C1704241lld:lifeskim
pubmed-article:19812200lifeskim:mentionsumls-concept:C0599894lld:lifeskim
pubmed-article:19812200lifeskim:mentionsumls-concept:C1257986lld:lifeskim
pubmed-article:19812200lifeskim:mentionsumls-concept:C1546857lld:lifeskim
pubmed-article:19812200lifeskim:mentionsumls-concept:C0441463lld:lifeskim
pubmed-article:19812200lifeskim:mentionsumls-concept:C1556066lld:lifeskim
pubmed-article:19812200lifeskim:mentionsumls-concept:C1619636lld:lifeskim
pubmed-article:19812200lifeskim:mentionsumls-concept:C1514873lld:lifeskim
pubmed-article:19812200lifeskim:mentionsumls-concept:C0069815lld:lifeskim
pubmed-article:19812200pubmed:issue9lld:pubmed
pubmed-article:19812200pubmed:dateCreated2009-10-21lld:pubmed
pubmed-article:19812200pubmed:abstractTextHeat shock proteins (HSPs) such as Hsp70, gp96, and Hsp90 have been shown to elicit intriguing, efficient CTL responses by cross-presentation via an as yet entirely unknown mechanism. Oxygen-regulated protein 150 (ORP150), also known as grp170, is an endoplasmic reticulum-resident HSP and is up-regulated by hypoxia. It has been demonstrated that ORP150 binds tumor-associated Ag peptides within cancer cells. Immunization with an ORP150-tumor Ag complex has been shown to generate tumor-specific CTLs. Most recently, it has been shown that exogenous ORP150 induces cross-presentation of a chaperoned Ag, thereby stimulating Ag-specific CTLs. However, the mechanism underlying this efficient cross-presentation is still unsolved. In this study, we show that the ORP150-precursor peptide complex can elicit CTL response through cross-presentation as well as the CD4(+) T cell response by dendritic cells. Furthermore, we observed that the internalized ORP150-peptide complex, but not OVA protein, which was not cross-presented, was sorted to the Rab5(+), EEA1(+) static early endosome, followed by translocation to a recycling endosome, where the ORP150-chaperoned peptide was processed and bound to MHC class I molecules. Moreover, we observed that immunization of mice with ORP150-peptide complexes elicited strong peptide-specific CTLs and antitumor effects in vivo. Our data indicate that targeting of the Ag to a "static" early endosme by ORP150 is required for the efficient cross-presentation.lld:pubmed
pubmed-article:19812200pubmed:languageenglld:pubmed
pubmed-article:19812200pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19812200pubmed:citationSubsetAIMlld:pubmed
pubmed-article:19812200pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19812200pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19812200pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19812200pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19812200pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19812200pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19812200pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19812200pubmed:statusMEDLINElld:pubmed
pubmed-article:19812200pubmed:monthNovlld:pubmed
pubmed-article:19812200pubmed:issn1550-6606lld:pubmed
pubmed-article:19812200pubmed:authorpubmed-author:MewePPlld:pubmed
pubmed-article:19812200pubmed:authorpubmed-author:OgawaSatoshiSlld:pubmed
pubmed-article:19812200pubmed:authorpubmed-author:SatoNoriyukiNlld:pubmed
pubmed-article:19812200pubmed:authorpubmed-author:YamamotoTakas...lld:pubmed
pubmed-article:19812200pubmed:authorpubmed-author:HirataKoichiKlld:pubmed
pubmed-article:19812200pubmed:authorpubmed-author:KamiguchiKenj...lld:pubmed
pubmed-article:19812200pubmed:authorpubmed-author:KutomiGoroGlld:pubmed
pubmed-article:19812200pubmed:authorpubmed-author:TorigoeToshih...lld:pubmed
pubmed-article:19812200pubmed:authorpubmed-author:HirohashiYosh...lld:pubmed
pubmed-article:19812200pubmed:authorpubmed-author:SaitoKeitaKlld:pubmed
pubmed-article:19812200pubmed:authorpubmed-author:TamuraYasuaki...lld:pubmed
pubmed-article:19812200pubmed:authorpubmed-author:OkuyaKoichiKlld:pubmed
pubmed-article:19812200pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19812200pubmed:day1lld:pubmed
pubmed-article:19812200pubmed:volume183lld:pubmed
pubmed-article:19812200pubmed:ownerNLMlld:pubmed
pubmed-article:19812200pubmed:authorsCompleteYlld:pubmed
pubmed-article:19812200pubmed:pagination5861-9lld:pubmed
pubmed-article:19812200pubmed:meshHeadingpubmed-meshheading:19812200...lld:pubmed
pubmed-article:19812200pubmed:meshHeadingpubmed-meshheading:19812200...lld:pubmed
pubmed-article:19812200pubmed:meshHeadingpubmed-meshheading:19812200...lld:pubmed
pubmed-article:19812200pubmed:meshHeadingpubmed-meshheading:19812200...lld:pubmed
pubmed-article:19812200pubmed:meshHeadingpubmed-meshheading:19812200...lld:pubmed
pubmed-article:19812200pubmed:meshHeadingpubmed-meshheading:19812200...lld:pubmed
pubmed-article:19812200pubmed:meshHeadingpubmed-meshheading:19812200...lld:pubmed
pubmed-article:19812200pubmed:meshHeadingpubmed-meshheading:19812200...lld:pubmed
pubmed-article:19812200pubmed:meshHeadingpubmed-meshheading:19812200...lld:pubmed
pubmed-article:19812200pubmed:meshHeadingpubmed-meshheading:19812200...lld:pubmed
pubmed-article:19812200pubmed:meshHeadingpubmed-meshheading:19812200...lld:pubmed
pubmed-article:19812200pubmed:meshHeadingpubmed-meshheading:19812200...lld:pubmed
pubmed-article:19812200pubmed:meshHeadingpubmed-meshheading:19812200...lld:pubmed
pubmed-article:19812200pubmed:meshHeadingpubmed-meshheading:19812200...lld:pubmed
pubmed-article:19812200pubmed:meshHeadingpubmed-meshheading:19812200...lld:pubmed
pubmed-article:19812200pubmed:meshHeadingpubmed-meshheading:19812200...lld:pubmed
pubmed-article:19812200pubmed:meshHeadingpubmed-meshheading:19812200...lld:pubmed
pubmed-article:19812200pubmed:meshHeadingpubmed-meshheading:19812200...lld:pubmed
pubmed-article:19812200pubmed:meshHeadingpubmed-meshheading:19812200...lld:pubmed
pubmed-article:19812200pubmed:meshHeadingpubmed-meshheading:19812200...lld:pubmed
pubmed-article:19812200pubmed:meshHeadingpubmed-meshheading:19812200...lld:pubmed
pubmed-article:19812200pubmed:meshHeadingpubmed-meshheading:19812200...lld:pubmed
pubmed-article:19812200pubmed:meshHeadingpubmed-meshheading:19812200...lld:pubmed
pubmed-article:19812200pubmed:meshHeadingpubmed-meshheading:19812200...lld:pubmed
pubmed-article:19812200pubmed:meshHeadingpubmed-meshheading:19812200...lld:pubmed
pubmed-article:19812200pubmed:meshHeadingpubmed-meshheading:19812200...lld:pubmed
pubmed-article:19812200pubmed:meshHeadingpubmed-meshheading:19812200...lld:pubmed
pubmed-article:19812200pubmed:year2009lld:pubmed
pubmed-article:19812200pubmed:articleTitleTargeting to static endosome is required for efficient cross-presentation of endoplasmic reticulum-resident oxygen-regulated protein 150-peptide complexes.lld:pubmed
pubmed-article:19812200pubmed:affiliationDepartment of Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan.lld:pubmed
pubmed-article:19812200pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19812200pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:10525entrezgene:pubmedpubmed-article:19812200lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:19812200lld:entrezgene